Anticoagulation Is the Default Treatment for PE and DVT
Anticoagulation treats the clot process itself, not just its consequences.
- Anticoagulation: First-line therapy (DOAC, heparin, or warfarin)
- Never: Filter as substitute (mechanical, not pharmacologic)
- Majority: PE from leg/pelvis DVT (iliofemoral segment highest risk)
- Minority: Filter-only patients (narrow exception cases)
Why anticoagulation comes before any device decision
Stops clot propagation and new embolization.
Does not remove existing thrombus.
Filters intercept consequences, not the disease.
Setting up the two-branch decision ahead
Two questions define the filter pathway.
Both relate to anticoagulation adequacy or safety.
Either answer alone can trigger filter placement.
Two Independent Paths Lead to the Same Filter Decision
Contraindication and recurrence are separate roads to one same conclusion.
- AC Contraindicated: Branch A (active major bleeding, etc.)
- Recurrent PE on AC: Branch B (therapeutic-dose failure)
- Sufficient: Either branch alone (triggers filter indication)
- No filter: Neither branch present (continue anticoagulation)
Branch A — absolute contraindication to anticoagulation
Active bleeding is the classic absolute contraindication.
Also: recent major surgery, hemorrhagic stroke, severe coagulopathy.
Branch B — recurrent PE despite adequate anticoagulation
New or progressive clot on therapeutic-dose therapy.
Implies drug failure; mechanical backup is added.
The Filter Blocks Migration Without Treating the Clot
A caged device catches fragments; it does not dissolve them.
- Infrarenal IVC: Deployment site (below renal vein ostia)
- Mechanical trap: Function (not thrombolytic)
- Preserved: Blood flow (struts allow flow around clot)
- Untreated: Underlying clot (AC still needed when safe)
Conical strut geometry traps large emboli
Apex faces upstream flow toward the heart.
Wide gaps let blood and small fragments pass.
A filter is a bridge, not a cure
Resume anticoagulation once safe.
Filter alone leaves clot source untreated.
Retrievable by Default, Permanent Only in Rare Cases
Most devices are designed to come back out once the risk passes.
- >90%: Retrievable filters used (of devices placed today)
- Rare: Permanent filter use (lifelong unresectable risk only)
- Nitinol: Retrieval material (self-expanding, snare-retrievable)
- Track for removal: Default plan (once contraindication resolves)
Retrievable filters — the default choice
Chosen when the contraindication is expected to be temporary.
Snared and removed via jugular access later.
Permanent filters — the narrow exception
Reserved for indefinite, unresectable-thrombus situations.
Retrieval judged unlikely ever to be feasible.
The Retrieval Clock Starts the Moment the Filter Goes In
Time in place trades pulmonary protection for rising device risk.
- ~0–12 wk: Ideal removal window (high retrieval success)
- ~12–18 wk: Caution window (retrieval harder, still feasible)
- 18–24+ wk: Overdue window (complication risk climbing)
- Thrombosis, perforation: Long-dwell risks (strut fracture, migration)
Why the removal window is tracked closely
Endothelialization makes late retrieval harder.
Early removal keeps success rates high.
What prolonged dwell time accumulates
Filter thrombosis, IVC perforation, strut fracture.
None of these help once AC resumes.
Placeholder: track every retrievable filter to a scheduled removal date.